Neuraxpharm Vows Swift Appeal Over Pulled EU Tecfidera Generics
CNS Specialist Says Decision Was ‘Rooted In A Highly Disputed Legal Interpretation’
• By David Wallace
Neuraxpharm says it will ‘swiftly contest’ the decision to pull generics from the market 
